Hinge Health (NYSE:HNGE) Trading Down 6.1% - Here's Why

Hinge Health Inc. (NYSE:HNGE - Get Free Report) fell 6.1% during trading on Wednesday . The stock traded as low as $43.60 and last traded at $44.07. 478,065 shares were traded during trading, a decline of 47% from the average session volume of 895,084 shares. The stock had previously closed at $46.92.

Analyst Upgrades and Downgrades

Several brokerages have commented on HNGE. Truist Financial assumed coverage on shares of Hinge Health in a research note on Monday, June 16th. They set a "buy" rating and a $48.00 price objective for the company. Barclays assumed coverage on shares of Hinge Health in a research report on Monday, June 16th. They set an "overweight" rating and a $43.00 price objective for the company. Bank of America assumed coverage on shares of Hinge Health in a report on Monday, June 16th. They set a "buy" rating and a $42.00 target price for the company. Evercore ISI began coverage on shares of Hinge Health in a report on Monday, June 16th. They set an "outperform" rating and a $50.00 target price for the company. Finally, Morgan Stanley assumed coverage on shares of Hinge Health in a report on Monday, June 16th. They issued an "overweight" rating and a $46.00 price objective for the company. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, Hinge Health presently has a consensus rating of "Moderate Buy" and an average target price of $46.00.

Hinge Health Stock Performance

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.